Toll Brothers
TOL
Meritage Homes
MTH
Taylor Morrison Home
TMHC
D.R. Horton
DHI
KB Home
KBH
US Stock MarketDetailed Quotes
ZBIO Zenas BioPharma
- 9.280
- -0.490-5.02%
Close Jan 8 16:00 ET
- 9.280
- 0.0000.00%
Post 20:01 ET
387.82MMarket Cap-3.01P/E (TTM)
10.120High9.190Low204.78KVolume9.680Open9.770Pre Close1.95MTurnover1.74%Turnover RatioLossP/E (Static)41.79MShares26.25152wk High1.08P/B109.13MFloat Cap7.79052wk Low--Dividend TTM11.76MShs Float26.251Historical High--Div YieldTTM9.52%Amplitude7.790Historical Low9.517Avg Price1Lot Size
About Zenas BioPharma Company
Zenas BioPharma, Inc. is a clinical-stage global biopharmaceutical company. The firm is mainly engaged in the development and commercialization of transformative immunology-based therapies for patients. The company was founded by Lonnie O. Moulder Jr on November 12, 2019 and is headquartered in Waltham, MA.
Company Profile
SymbolZBIO
Company NameZenas BioPharma
Listing DateSep 13, 2024
Issue Price17.00
Founded2019
CEOMr. Leon O. Moulder, Jr
MarketNASDAQ
Employees114
Fiscal Year Ends12-31
Address852 Winter Street,Suite 250
CityWaltham
ProvinceMassachusetts
CountryUnited States of America
Zip Code02451
Websitehttps://www.zenasbio.com
Company Executives
- Name
- Position
- Salary
- Leon O. Moulder, Jr
- Chief Executive Officer and Chairman of the Board
- 2.60M
- Jennifer A. Fox
- Principal Accounting Officer, Chief Business Officer and Chief Financial Officer
- 2.57M
- Orlando Oliveira
- Chief Commercial Officer
- --
- Joseph Farmer
- President and Chief Operating Officer
- 1.29M
- James P. Boylan, M.B.A.
- Independent Director
- --
- Ting Xiao
- Independent Director
- --
- Patrick G. Enright, M.B.A.
- Independent Director
- --
- Dr. Hongbo Lu, PhD
- Independent Director
- --
- Patricia L. Allen
- Independent Director
- --
- Jake R. Nunn
- Independent Director
- --
- Dr. John J. Orloff, M.D.
- Independent Director
- --
- Tomas Kiselak
- Independent Director
- --
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
